{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:53:19Z","timestamp":1771995199797,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.054","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T03:11:11Z","timestamp":1551323471000},"page":"1721-1724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is the test for irreversibility of tetanus toxoids still relevant?"],"prefix":"10.1016","volume":"37","author":[{"given":"Heike A.","family":"Behrensdorf-Nicol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.054_b0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.02.054_b0010","unstructured":"Council of Europe. Tetanus vaccine (adsorbed): European Pharmacopoeia 9.5. Monograph 0452; 2018."},{"key":"10.1016\/j.vaccine.2019.02.054_b0015","unstructured":"Council of Europe. Tetanus vaccine for veterinary use: European Pharmacopoeia 9.5. Monograph 0697; 2018."},{"key":"10.1016\/j.vaccine.2019.02.054_b0020","series-title":"New approaches to stabilisation of vaccines potency. Dev. biol. stand. Basel, Karger","first-page":"113","article-title":"Reasons for instability of bacterial vaccines","author":"Corbel","year":"1996"},{"key":"10.1016\/j.vaccine.2019.02.054_b0025","series-title":"Proceedings of an informal consultation on the World Health Organization requirements for diphtheria, tetanus, pertussis and combined vaccines","first-page":"12","article-title":"Tetanus toxoid: \u201cReversion\u201d or residual toxicity?","author":"Latham","year":"1988"},{"key":"10.1016\/j.vaccine.2019.02.054_b0030","first-page":"177","article-title":"The toxoiding of purified diphtheria toxin","volume":"44","author":"Linggood","year":"1963","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2019.02.054_b0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7883\/yoken1952.24.183","article-title":"Reversion of toxicity of diphtheria toxoid","volume":"24","author":"Akama","year":"1971","journal-title":"Japan J Med Sci Biol"},{"key":"10.1016\/j.vaccine.2019.02.054_b0040","first-page":"149","article-title":"Irreversibility of toxoids. An improved method of testing","volume":"34","author":"Stainer","year":"1977","journal-title":"Develop Biol Standard"},{"key":"10.1016\/j.vaccine.2019.02.054_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7883\/yoken1952.24.181","article-title":"Reversion of toxicity of tetanus toxoid","volume":"24","author":"Akama","year":"1971","journal-title":"Japan J Med Sci Biol"},{"key":"10.1016\/j.vaccine.2019.02.054_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/biol.1993.1072","article-title":"Anomalous symptoms in mice injected with reverted tetanus toxoid","volume":"21","author":"Knight","year":"1993","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.02.054_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0307-4412(79)90013-X","article-title":"Denaturation at the optimum temperature","volume":"7","author":"Barton","year":"1979","journal-title":"Biochem Educ"},{"key":"10.1016\/j.vaccine.2019.02.054_b0060","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.tiv.2009.12.018","article-title":"In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step","volume":"24","author":"Behrensdorf-Nicol","year":"2010","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.vaccine.2019.02.054_b0065","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/j.vaccine.2013.10.028","article-title":"Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production","volume":"31","author":"Behrensdorf-Nicol","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.054_b0070","unstructured":"European Commission. Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union L 276\/33-79; 2010."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T20:19:30Z","timestamp":1606594770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302610"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the test for irreversibility of tetanus toxoids still relevant?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}